V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626483 | 330006615 | EEI00 | 1650 | X724 | 1 | 2016-03-19 | DOXORUBICIN | 330002879 | 330003362 | 330006616 |
| 16626484 | 330006615 | EPH | 2600 | N/A | 5 | 2016-03-20 | DACTINOMYCIN | 330002879 | 330003362 | 330006616 |
| 16626485 | 330006615 | EGQ01 | null | X721 | 1 | 2016-03-21 | ETOPOSIDE | 330002879 | 330003362 | 330006616 |
| 16626486 | 330006615 | EEI00 | 1710 | X724 | 2 | 2016-03-21 | AZD9150 | 330002879 | 330003362 | 330006616 |
| 16626487 | 330006615 | ECL01 | 5600 | X721 | 2 | 2016-03-21 | CYTARABINE | 330002879 | 330003362 | 330006616 |
| 16626488 | 330006615 | EUZ | 5600 | X721 | 1 | 2016-03-21 | IFOSFAMIDE | 330002879 | 330003362 | 330006616 |
| 16626489 | 330006615 | EN201 | 110 | null | 1 | 2016-03-21 | DOCETAXEL | 330002879 | 330003362 | 330006616 |
| 16626490 | 330006615 | EE813 | 6210 | X721 | 1 | 2016-03-21 | FLUOROURACIL | 330002879 | 330003362 | 330006616 |
| 16626491 | 330006617 | EJR | 62 | X724 | 2 | 2018-01-06 | TRIAL | 330002884 | 330003366 | 330006618 |
| 16626492 | 330006618 | EGU08 | 0.75 | null | 1 | 2014-11-15 | AZD9150 | 330002895 | 330010244 | 330006619 |
| 16626493 | 330006618 | EPH | 50 | X721 | 1 | 2014-11-16 | IFOSFAMIDE | 330002895 | 330010244 | 330006619 |
| 16626494 | 330006618 | EEI00 | 46.4 | null | 1 | 2014-11-16 | NOT CHEMO | 330002895 | 330010244 | 330006619 |
| 16626495 | 330006618 | EOF | 4240 | null | 2 | 2014-11-24 | TOPOTECAN | 330002895 | 330010244 | 330006619 |
| 16626496 | 330006618 | E1UZ0 | 2640 | null | 5 | 2014-11-25 | MULTIPLE | 330002895 | 330010244 | 330006619 |
| 16626497 | 330006624 | E0N03 | 565 | X729 | 1 | 2018-04-09 | DOXORUBICIN | 330002942 | 330003372 | 330006625 |
| 16626498 | 330006626 | EUZ | 75 | X724 | 1 | 2013-12-20 | NOT CHEMO | 330002949 | 330003375 | 330006627 |
| 16626499 | 330006627 | EEI00 | 425 | null | 1 | 2013-07-12 | DOXORUBICIN | 330002955 | 330003376 | 330006628 |
| 16626500 | 330006628 | EK1EN | 562.5 | N/A | 1 | 2014-08-07 | ETOPOSIDE | 330002960 | 330003377 | 330006629 |
| 16626501 | 330006628 | ECL02 | 14 | X721 | 1 | 2014-08-07 | DAUNORUBICIN | 330002960 | 330003377 | 330006629 |
| 16626502 | 330006628 | ETG | 3000 | X721 | null | 2014-08-08 | CARBOPLATIN | 330002960 | 330003377 | 330006629 |
| 16626503 | 330006628 | EEI00 | 49 | null | 1 | 2014-08-30 | NOT CHEMO | 330002960 | 330003377 | 330006629 |
| 16626504 | 330006629 | EEI00 | 400 | null | 1 | 2015-02-17 | VINCRISTINE | 330002961 | 330003378 | 330006630 |
| 16626505 | 330006629 | EJRNN | 1.4 | X724 | 1 | 2015-02-20 | CYTARABINE | 330002961 | 330003378 | 330006630 |
| 16626506 | 330006629 | ECL02 | 110 | X721 | 2 | 2015-02-20 | CYCLOPHOSPHAMIDE | 330002961 | 330003378 | 330006630 |
| 16626507 | 330006629 | EK1EN | 1100 | X292 | 1 | 2015-02-20 | TRIAL | 330002961 | 330003378 | 330006630 |
| 16626508 | 330006629 | E1UZ0 | 2 | null | 1 | 2015-02-23 | CYTARABINE | 330002961 | 330003378 | 330006630 |
| 16626509 | 330006629 | ED301 | 31 | null | 2 | 2015-02-23 | DOXORUBICIN | 330002961 | 330003378 | 330006630 |
| 16626510 | 330006629 | EEX02 | 0.9 | X724 | 1 | 2015-02-23 | CISPLATIN | 330002961 | 330003378 | 330006630 |
| 16626511 | 330006629 | ELW | 150 | X721 | 1 | 2015-02-23 | DOCETAXEL | 330002961 | 330003378 | 330006630 |
| 16626512 | 330006629 | EN901 | 1950 | X721 | 1 | 2015-02-24 | FLUOROURACIL | 330002961 | 330003378 | 330006630 |
| 16626515 | 330006635 | EEI00 | 1.05 | null | 1 | 2018-05-10 | THIOTEPA | 330002986 | 330003385 | 330006636 |
| 16626516 | 330006635 | EEI00 | 110 | null | 1 | 2018-05-15 | CYTARABINE | 330002986 | 330003385 | 330006636 |
| 16626517 | 330006638 | EEI00 | 300 | null | 1 | 2015-03-02 | MESNA | 330002999 | 330003389 | 330006639 |
| 16626518 | 330006641 | E0N03 | 0.75 | X292 | 1 | 2013-11-25 | ETOPOSIDE | 330003012 | 330003392 | 330006642 |
| 16626519 | 330006641 | EEI00 | 1.5 | X724 | 1 | 2013-11-25 | CYTARABINE | 330003012 | 330003392 | 330006642 |
| 16626520 | 330006641 | EKA | 3280 | null | 1 | 2013-11-25 | IFOSFAMIDE | 330003012 | 330003392 | 330006642 |
| 16626521 | 330006641 | ECL01 | null | X729 | null | 2013-11-25 | ETOPOSIDE | 330003012 | 330003392 | 330006642 |
| 16626522 | 330006641 | ED301 | 60 | null | 1 | 2013-11-25 | IPILIMUMAB | 330003012 | 330003392 | 330006642 |
| 16626523 | 330006641 | EEI00 | 160 | X729 | 1 | 2013-11-25 | IFOSFAMIDE | 330003012 | 330003392 | 330006642 |
| 16626524 | 330006641 | EJU04 | 1700 | null | 1 | 2013-11-25 | FLUOROURACIL | 330003012 | 330003392 | 330006642 |
| 16626525 | 330006641 | ENW | 8 | X721 | 2 | 2013-11-26 | NOT CHEMO | 330003012 | 330003392 | 330006642 |
| 16626526 | 330006641 | EUH | 8 | null | 1 | 2013-11-26 | STEROID | 330003012 | 330003392 | 330006642 |
| 16626527 | 330006644 | ECL01 | 170 | X729 | 1 | 2017-07-13 | IRINOTECAN | 330003017 | 330003395 | 330006645 |
| 16626528 | 330006644 | EGU08 | 50 | X724 | 1 | 2017-07-13 | VINCRISTINE | 330003017 | 330003395 | 330006645 |
| 16626529 | 330006644 | EUZ | 80 | X721 | 1 | 2017-07-14 | IFOSFAMIDE | 330003017 | 330003395 | 330006645 |
| 16626530 | 330006644 | ED301 | 430 | null | 1 | 2017-07-20 | TRIAL | 330003017 | 330003395 | 330006645 |
| 16626531 | 330006644 | EGU08 | 85 | null | 1 | 2017-07-24 | IRINOTECAN | 330003017 | 330003395 | 330006645 |
| 16626532 | 330006644 | EEI00 | 3280 | null | 1 | 2017-07-24 | MESNA | 330003017 | 330003395 | 330006645 |
| 16626533 | 330006644 | EII | 6200 | X724 | 1 | 2017-07-25 | FLUOROURACIL | 330003017 | 330003395 | 330006645 |
| 16626534 | 330006644 | ENW | 8 | X724 | 1 | 2017-07-25 | STEROID | 330003017 | 330003395 | 330006645 |